Should we move beyond VEGF inhibition in metastatic colorectal cancer? Lessons from early phase clinical trials

Sukeshi R. Patel, Anand B. Karnad, Norma S. Ketchum, Brad H. Pollock, John Sarantopoulos, Steven Weitman, Devalingam Mahalingam

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Should we move beyond VEGF inhibition in metastatic colorectal cancer? Lessons from early phase clinical trials'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience